{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:23:48Z","timestamp":1762431828267,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.anpedi.2019.12.014","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T19:45:37Z","timestamp":1582573537000},"page":"59.e1-59.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inmunoterapia con c\u00e9lulas CAR-T en hematooncolog\u00eda pedi\u00e1trica"],"prefix":"10.1016","volume":"93","author":[{"given":"Isabel","family":"Mirones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Pati\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garbi\u00f1e","family":"Lizeaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Moraleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mirones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Sisinni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Garc\u00eda-Mor\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Rives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Pati\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Verd\u00fa-Amor\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garbi\u00f1e","family":"Lizeaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Guerra-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Moraleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"S\u00e1nchez-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Blanquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisse M.","family":"van Santen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2019.12.014_bib0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)","volume":"238","author":"Farber","year":"1948","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2019.12.014_bib0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12185-016-2039-6","article-title":"Biology and clinical application of CAR T cells for B cell malignancies","volume":"104","author":"Davila","year":"2016","journal-title":"Int J Hematol."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrc.2016.97","article-title":"Engineered T cells: Thepromise and challenges of cancerimmunotherapy","volume":"16","author":"Fesnak","year":"2016","journal-title":"Nat RevCancer."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR\u03b6\/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0225","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.161.6.2791","article-title":"Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product","volume":"161","author":"Finney","year":"1998","journal-title":"J Immunol."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0230","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2019.12.014_bib0240","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1158\/1078-0432.CCR-17-0075","article-title":"Memory T cellsexpressingan NKG2D-CAR efficiently target osteosarcomacells","volume":"23","author":"Fern\u00e1ndez","year":"2017","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0245","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcyt.2019.01.003","article-title":"Chimericantigen receptor\u2013T celltherapymanufacturing: modellingtheeffect of offshore productiononaggregatecost of goods","volume":"21","author":"Harrison","year":"2019","journal-title":"Cytotherapy."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0250","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood-2018-10-882944","article-title":"Fratricide-resistant CD1a-specific CAR T-cells for the treatment of cortical T-cell acute lymphoblastic leukemia","volume":"133","author":"S\u00e1nchez-Mart\u00ednez","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.anpedi.2016.07.007","article-title":"Ensayos cl\u00ednicos precoces en oncolog\u00eda pedi\u00e1trica en Espa\u00f1a: una perspectiva nacional","volume":"87","author":"Bautista","year":"2017","journal-title":"An Pediatr (Barc). 2017"},{"key":"10.1016\/j.anpedi.2019.12.014_bib0260","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40272-018-0297-x","article-title":"Pediatric cancer immunotherapy: Opportunities and challenges","volume":"20","author":"Wedekind","year":"2018","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0265","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/86.15.1159","article-title":"Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2","volume":"86","author":"Rosenberg","year":"1994","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0270","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013modified t cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0275","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"New England Journal of Medicine."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0280","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"ProcNatlAcadSci U S A."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0285","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2217\/imt-2017-0045","article-title":"Atypical\u201d CAR T cells: NKG2D and Erb-B as examples of natural receptor\/ligands to target recalcitrant solid tumors","volume":"9","author":"Gilham","year":"2017","journal-title":"Immunotherapy."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0290","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3389\/fimmu.2019.02361","article-title":"GMP-Compliant\u00a0Manufacturing\u00a0of NKG2D CAR Memory T Cells Using CliniMACS Prodigy","volume":"10","author":"Fern\u00e1ndez","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0295","unstructured":"U.S. Food&DrugAdministration, 2018 [consultado 9 Mar 2018]. Disponible en https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm606540.htm."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0300","unstructured":"U.S. Food&DrugAdministration, 2018 [consultado 12 Mar 2018]. Disponible en https:\/\/www.fda.gov\/biologicsbloodvaccines\/cellulargenetherapyproducts\/approvedproducts\/ucm581222.htm."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0305","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bbmt.2018.02.018","article-title":"Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center","volume":"24","author":"Perica","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.omtm.2018.11.010","article-title":"Development of a Novel Anti-CD19 chimeric antigen receptor: A paradigm for an affordable CAR T cell production at academic institutions","volume":"12","author":"Castella","year":"2018","journal-title":"MolTher Methods Clin Dev."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtm.2019.01.010","article-title":"EU RegulatoryPathwaysforATMPs: Standard Accelerated and AdaptivePathways to Marketing Authorisation","volume":"13","author":"Detela","year":"2019","journal-title":"MolTher Methods Clin Dev."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.omtm.2017.08.005","article-title":"Accelerating patients\u2019 access to advanced therapies in the EU","volume":"7","author":"Elsanhoury","year":"2017","journal-title":"MolTher Methods Clin Dev."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fphar.2019.00111","article-title":"The new paradigms in clinicalresearch: Fromearly access programs to the novel therapeutic approaches for unmet medical needs","volume":"10","author":"Scavone","year":"2019","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0330","first-page":"11","article-title":"Innovation and competition in advancedtherapy medicinal products","author":"Seoane-Vazquez","year":"2019","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0335","first-page":"158","article-title":"Cell and gene therapies: European view on challenges in translation and how to address them","volume":"5","author":"Bubela","year":"2018","journal-title":"Front Med (Lausanne). 2018"},{"key":"10.1016\/j.anpedi.2019.12.014_bib0340","first-page":"182","article-title":"Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework","volume":"4","author":"Carvalho","year":"2017","journal-title":"Front Med (Lausanne). 2017"},{"key":"10.1016\/j.anpedi.2019.12.014_bib0345","first-page":"120","article-title":"Global regulatory differences for gene and cell based therapies: Consequences and implications for patient access and therapeutic innovation","volume":"103","author":"Coppen","year":"2018","journal-title":"ClinPharmacolTher. 2018"},{"key":"10.1016\/j.anpedi.2019.12.014_bib0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/hgtb.2017.096","article-title":"A guide to approaching regulatory considerations for lentiviral mediated gene therapies","volume":"28","author":"White","year":"2017","journal-title":"Hum Gene Ther Methods."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0355","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fbioe.2018.00130","article-title":"Recent Progress in European Advanced Therapy Medicinal Products and Beyond","volume":"6","author":"Yu","year":"2018","journal-title":"Front Bioeng Biotechnol."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0360","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcyt.2018.11.009","article-title":"Manufacturing chimeric antigen receptor T cells: issues and challenges","volume":"21","author":"Roddie","year":"2019","journal-title":"Cytotherapy."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0365","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fmed.2018.00150","article-title":"Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges","volume":"5","author":"Iyer","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0370","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/rme-2017-0051","article-title":"Challenges of running a GMP facility for regenerative medicine in a public hospital","volume":"12","author":"Viga","year":"2017","journal-title":"Regen Med."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0375","unstructured":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios Parte IV. Directrices sobre normas de correcta fabricaci\u00f3n espec\u00edficas para Medicamentos de Terapia Avanzada [consultado 1 Jun 2018]. Disponible en https:\/\/www.aemps.gob.es\/industria\/inspeccionNCF\/guiaNCF\/docs\/normas-correcta-fabricacion\/nueva-guia-NCF-ATMPs.pdf."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0380","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bej.2018.05.014","article-title":"Cost-effectivebioprocessdesignforthe manufacture of allogeneic CAR-T celltherapiesusing a decisional toolwithmulti-attributedecision-makinganalysis","volume":"137","author":"Jenkins","year":"2018","journal-title":"Biochemical Engineering Journal."},{"issue":"10.","key":"10.1016\/j.anpedi.2019.12.014_bib0385","article-title":"Allogeneic CAR-T Cells: More than ease of access?","volume":"7","author":"Graham","year":"2018","journal-title":"Cells."},{"key":"10.1016\/j.anpedi.2019.12.014_bib0390","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000495772","article-title":"Functionality and Cell Senescence of CD4\/CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy Platform","volume":"46","author":"Aleksandrova","year":"2019","journal-title":"Transfus Med Hemother."}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403320300163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403320300163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:51:09Z","timestamp":1761663069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403320300163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1695403320300163"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2019.12.014","relation":{},"ISSN":["1695-4033"],"issn-type":[{"type":"print","value":"1695-4033"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inmunoterapia con c\u00e9lulas CAR-T en hematooncolog\u00eda pedi\u00e1trica","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2019.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}